Evaluation of 3‐ and 4‐Phenoxybenzamides as Selective Inhibitors of the Mono‐ADP‐Ribosyltransferase PARP10-Reference-Cited by-同舟云学术

Evaluation of 3‐ and 4‐Phenoxybenzamides as Selective Inhibitors of the Mono‐ADP‐Ribosyltransferase PARP10

Published:2021-06-19 Issue:10 Volume:10 Page:939-948
ISSN:2191-1363
Container-title:ChemistryOpen
language:en
Short-container-title:ChemistryOpen

Author:

Korn Patricia¹,Classen Arno²,Murthy Sudarshan³^ORCID,Guareschi Riccardo⁴,Maksimainen Mirko M.³^ORCID,Lippok Barbara E.¹,Galera‐Prat Albert³^ORCID,Sowa Sven T.³^ORCID,Voigt Catharina¹,Rossetti Giulia⁴⁵⁶^ORCID,Lehtiö Lari³^ORCID,Bolm Carsten²^ORCID,Lüscher Bernhard¹^ORCID

Affiliation:

1. Institute of Biochemistry and Molecular Biology Medical Faculty RWTH Aachen University Pauwelsstrasse 30 52074 Aachen Germany

2. Institute of Organic Chemistry RWTH Aachen University Landoltweg 1 52056 Aachen Germany

3. Faculty of Biochemistry and Molecular Medicine & Biocenter Oulo University of Oulu Pentti Kaiteran katu 1 90014 Oulu Finland

4. Institute for Advanced Simulation (IAS-5)/Institute of Neuroscience and Medicine (INM-9) Jülich Supercomputing Centre (JSC) Forschungszentrum Jülich Wilhelm-Johnen-Strasse 52425 Jülich Germany

5. Juelich Supercomputing Center (JSC) Forschungszentrum Jülich Wilhelm-Johnen-Strasse 52425 Jülich Germany

6. Department of Oncology, Hematology and Stem Cell Transplantation Medical Faculty RWTH Aachen University Pauwelsstrasse 30 52074 Aachen Germany

Funder

Academy of Finland

Publisher

Wiley

Subject

General Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/open.202100087

Reference73 articles.

2. ADP-Ribosylation, a Multifaceted Posttranslational Modification Involved in the Control of Cell Physiology in Health and Disease